$12.35
−1.28%0
Insider buys (3m)
1
Insider sells (3m)
-$1.3K
Net value (3m)
-22.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 31, 2026 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 464 | $2.70 |
| Feb 2, 2026 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 534 | $4.86 |
| Jan 14, 2026 | BAKER BROS. ADVISORS LP · director | M-Exempt | 25,005,240 | $0.00 |
| Jan 14, 2026 | BAKER BROS. ADVISORS LP · director | M-Exempt | 2,299,656 | $0.00 |
| Dec 19, 2025 | EPIC Bpifrance · other: Member of 10% owner group | Sale | 2,036,990 | $4.84 |
| Dec 19, 2025 | EPIC Bpifrance · other: Member of 10% owner group | Sale | 40,000 | $5.28 |
| Dec 19, 2025 | EPIC Bpifrance · other: Member of 10% owner group | Sale | 1,292,103 | $4.19 |
| Nov 25, 2025 | Mohideen Pharis · officer: Chief Medical Officer | A-Award | 44,000 | $0.00 |
| Nov 25, 2025 | Mohideen Pharis · officer: Chief Medical Officer | A-Award | 253,000 | $2.90 |
| Nov 25, 2025 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 6,496 | $2.88 |
| Nov 25, 2025 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 1,624 | $2.77 |
| Nov 24, 2025 | Boucinha Virginie · officer: Chief Financial Officer | A-Award | 32,000 | $0.00 |
| Nov 24, 2025 | Trapp Kevin Michael · officer: Chief Commercial Officer | A-Award | 316,250 | $2.90 |
| Nov 24, 2025 | Trapp Kevin Michael · officer: Chief Commercial Officer | A-Award | 55,000 | $0.00 |
| Nov 24, 2025 | Tasse Daniel · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 964,000 | $2.90 |
| Nov 24, 2025 | Boucinha Virginie · officer: Chief Financial Officer | A-Award | 192,000 | $2.90 |
| Jul 31, 2025 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 464 | $2.22 |
| May 27, 2025 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 397 | $1.84 |
| Mar 31, 2025 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | A-Award | 2,299,656 | $0.00 |
| Mar 31, 2025 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | A-Award | 25,005,240 | $0.00 |
| Jan 31, 2025 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 600 | $0.85 |
| Dec 5, 2024 | Tasse Daniel · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 813,200 | $0.89 |
| Nov 27, 2024 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 565 | $0.57 |
| Nov 27, 2024 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 342 | $0.53 |
| Nov 25, 2024 | Mohideen Pharis · officer: Chief Medical Officer | A-Award | 35,000 | $0.00 |
| Nov 25, 2024 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 2,350 | $0.54 |
| Nov 25, 2024 | Boucinha Virginie · officer: Chief Financial Officer | A-Award | 113,000 | $0.75 |
| Nov 25, 2024 | Boucinha Virginie · officer: Chief Financial Officer | A-Award | 19,000 | $0.00 |
| Nov 25, 2024 | Mohideen Pharis · officer: Chief Medical Officer | A-Award | 215,000 | $0.75 |
| Jul 31, 2024 | Mohideen Pharis · officer: Chief Medical Officer | Sale | 1,785 | $0.98 |
Institutional positioning
13F filings over the trailing two quarters
New 47Increased 29Reduced 39Sold out 11
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BIOIMPACT CAPITAL LLC | Increased | 5,213,361 | May 15, 2026 |
| MPM BioImpact LLC | Reduced | 3,666,284 | Aug 14, 2026 |
| VIVO CAPITAL, LLC | Increased | 2,667,569 | May 20, 2026 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | Reduced | 2,219,386 | May 13, 2026 |
| SIREN, L.L.C. | Unchanged | 1,857,362 | May 14, 2026 |
| Siren, L.L.C. | Unchanged | 1,857,362 | Aug 13, 2026 |
| Vivo Capital, LLC | Reduced | 1,844,758 | Aug 14, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 1,653,350 | Aug 14, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 1,461,425 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 1,461,425 | Aug 14, 2026 |
| Artisan Partners Limited Partnership | Reduced | 1,372,851 | Aug 13, 2026 |
| UBS Group AG | Increased | 1,313,439 | Aug 13, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | New Position | 1,012,866 | May 18, 2026 |
| PERCEPTIVE ADVISORS LLC | New Position | 964,391 | May 29, 2026 |
| MORGAN STANLEY | Increased | 954,908 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 31, 2026